AnaptysBio Inc (ANAB)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 631.07M
P/E Ratio
0.00
Revenue (TTM)
$ 123.16M
Volume
0
52W High
$ 40.70
52W Low
$ 12.21
Dividend Yield
0.00%
Beta
-0.18
Technicals
50-Day MA
23.1834
200-Day MA
19.8871
52 Week High
40.7
52 Week Low
12.21
About ANAB
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics.
Employees
136
Headquarters
San Diego, CA
CEO
Mr. Daniel R. Faga
Latest News
ANAB Establishes the Digital Technology Initiative and AI Task Force - PR Newswire
Yesterday • Google News
Rafferty Asset Management LLC Cuts Stake in AnaptysBio, Inc. $ANAB - MarketBeat
10 hours ago • Google News